Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases. [PDF]
Fasshauer M +7 more
europepmc +1 more source
Newborn Screening for Primary Immunodeficiency Diseases: The Past, the Present and the Future
Primary immunodeficiency diseases (PID) are a heterogeneous group of disorders caused by inborn errors of immunity, with affected children presenting with severe, recurrent or unusual infections.
Jovanka R. King +2 more
semanticscholar +1 more source
Patient-reported outcomes in patients with primary immunodeficiency diseases in Japan: baseline results from a prospective observational study. [PDF]
Kanegane H +6 more
europepmc +1 more source
Effects of Body Mass and Age on the Pharmacokinetics of Subcutaneous or Hyaluronidase-facilitated Subcutaneous Immunoglobulin G in Primary Immunodeficiency Diseases. [PDF]
Li Z +4 more
europepmc +1 more source
Gastrointestinal manifestations in children with primary immunodeficiency diseases [PDF]
Shereen M. Reda
openalex +1 more source
Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study [PDF]
Michaela Koehm +9 more
openalex +1 more source
The Association of Two Rare Diseases is Not Rare: Primary Immunodeficiencies and Autoimmune Liver Diseases [PDF]
Şefika Nur Ayar +4 more
openalex +1 more source
Cutaneous Manifestations of Primary Immunodeficiency Diseases in Children
Primary immunodeficiency diseases (PIDs) are rare but include severe conditions found predominantly in children, Most PIDs have cutaneous manifestations that may be important as early diagnostic features.
Athar Moin +4 more
doaj
The research on the treatment of primary immunodeficiency diseases by hematopoietic stem cell transplantation: A bibliometric analysis from 2013 to 2022. [PDF]
Hu S +8 more
europepmc +1 more source

